The pharmaceutical industry constantly seeks novel targets and effective chemical tools to develop treatments for debilitating diseases. Protein Arginine Deiminase 4 (PAD4) has emerged as a significant target, particularly in the context of inflammatory and autoimmune disorders. GSK484, a potent and selective inhibitor of PAD4 (CAS 1652591-81-5), plays a crucial role in this area by enabling in-depth research into PAD4's involvement in disease pathogenesis and potential therapeutic strategies.

GSK484's primary function is to inhibit PAD4, an enzyme that catalyzes the conversion of arginine to citrulline. This modification, known as citrullination, is a critical process that, when aberrant, is closely linked to the development of autoimmune diseases such as rheumatoid arthritis. By modulating PAD4 activity, researchers can investigate how to disrupt these pathological pathways. GSK484's high selectivity for PAD4 over other PAD enzymes makes it an ideal agent for targeted studies, ensuring that observed effects are directly attributable to PAD4 inhibition.

The relevance of GSK484 in pharmaceutical research and development is multifaceted. It serves as an invaluable tool in preclinical studies to:

• Validate PAD4 as a Drug Target: By demonstrating the effects of PAD4 inhibition in cellular and animal models, GSK484 helps solidify PAD4's status as a viable target for drug development.
• Screen for New Therapeutics: GSK484 can be used as a benchmark compound in high-throughput screening assays to identify novel molecules with similar or improved PAD4 inhibitory activity.
• Elucidate Disease Mechanisms: Its specific action allows researchers to dissect the roles of PAD4 and citrullination in disease progression, paving the way for more targeted treatment approaches.
• Study Neutrophil Extracellular Traps (NETs): By inhibiting NET formation, GSK484 aids in understanding the contribution of NETs to inflammatory diseases and exploring strategies to control them.

For pharmaceutical companies and research institutions looking to buy GSK484, sourcing from a reliable supplier in China is a strategic choice. We are a dedicated manufacturer offering high-quality GSK484 hydrochloride (GSK484 HCl) at competitive prices. Ensuring a consistent supply of this research chemical is vital for ongoing drug discovery efforts. When you purchase GSK484, you are obtaining a compound that supports critical early-stage research, potentially leading to the next generation of therapies.

The ability to procure compounds like GSK484 efficiently and cost-effectively is crucial for budget-conscious R&D programs. We provide transparent pricing and detailed technical information to assist you in your procurement decisions. Engaging with a trusted source like ours ensures that you receive a product that meets stringent quality standards, thereby supporting the integrity of your research.

In conclusion, GSK484 (CAS 1652591-81-5) is more than just a chemical compound; it is a critical research enabler in the pharmaceutical sector. Its precise mechanism of action and selectivity make it indispensable for understanding and targeting PAD4-related diseases. We invite you to contact us to discuss your requirements and obtain a quote for GSK484, your trusted partner in advancing pharmaceutical innovation.